$CLVT Cashflow Statement | Understand Stock

$CLVT

$1.82 -$0.05 (2.67%) Close

$CLVT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows From Operating Activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Bad debt expense
Depreciation and amortization
Share-based compensation
Noncash Impairment, Leases
Gain (Loss) on Foreign Currency Forward Contracts
Restructuring and other impairments, including goodwill
Loss (gain) on foreign currency forward contracts
Mark to market (gain) loss on contingent shares
Fair value adjustment of warrants
Gain on sale from divestitures
Gain on legal settlement
Deferred income taxes
Amortization and write-off of debt issuance costs
Other operating activities
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenues
Operating lease right of use assets
Operating lease liabilities
Operating leases, net
Other liabilities

Net cash provided by operating activities
Cash Flows From Investing Activities
Capital expenditures
Payments to Acquire Businesses, Net of Cash Acquired
Acquisition of intangible assets
Proceeds from divestitures, net of cash divested
Net cash used for investing activities

Cash Flows From Financing Activities
Proceeds from revolving credit facility
Redemption of Notes not exchanged
Principal payments on debt
Repayments of revolving credit facility
Proceeds From Debt Issuance Costs
Payment of debt issuance costs and discounts
Contingent purchase price payment
Proceeds from issuance of preferred shares
Proceeds from issuance of ordinary shares
Proceeds from issuance of treasury shares
Proceeds from Issuance of Debt
Payment of debt issuance and extinguishment costs
Payments for Repurchase of Equity
Cash dividends on preferred shares
Proceeds from warrant exercises
Proceeds from stock options exercised
Payments related to finance lease
Payments related to tax withholding for share-based compensation
Other financing activities
Net cash used for financing activities

Effects of exchange rates
Net increase in cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Net (decrease) increase in restricted cash
Net increase in cash held for sale
Net change in cash and cash equivalents, including restricted cash
Cash and cash equivalents
Cash and cash equivalents, beginning of period
Restricted cash, beginning of period
Cash and cash equivalents, including restricted cash, beginning of period
Cash and cash equivalents, end of period
Restricted cash, end of period
Less: Cash included in assets held for sale, end of period
Cash and cash equivalents, including restricted cash, end of period
Cash paid for interest
Cash paid for income tax
Capital expenditures included in accounts payable
Clarivate stock to be issued
Shares issued to Capri Acquisition Topco Limited
Retirement of treasury shares
Value of stock issued
DRG
CPA Global
Shares issued as dividends on our 5.25% Series A Mandatory Convertible Preferred Shares
Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares
Total Non-Cash Financing Activities

Comments